Differential control of 2-AG’s activity at CB1R by ABHD6 and MAGL
ABHD6 和 MAGL 对 CB1R 上 2-AG 活性的差异控制
基本信息
- 批准号:10664172
- 负责人:
- 金额:$ 19.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:2-arachidonylglycerolABHD6 geneAddressAdverse effectsAffectAgonistApplications GrantsBDKRB2 geneBiological ModelsBiosensorBradykininBrainCNR1 geneCannabinoidsCell LineCellsChronicCorpus striatum structureDevelopmentDrug AddictionElectrophysiology (science)EndocannabinoidsEnzymesFluorescence MicroscopyGoalsHydrolaseMAGL inhibitorMapsMeasuresMediatingMolecularMonoacylglycerol LipasesMusN-MethylaspartateNeuronsPresynaptic TerminalsProductionPropertyReceptor SignalingResearchRoleSignal TransductionSliceStimulusSynaptic TransmissionSystemTestingTherapeuticTimeTransfectionVeratridineWorkabuse liabilitycell typeendocannabinoid signalinglipoprotein lipasenervous system disordernovelnovel therapeuticspharmacologicpostsynapticpresynapticreceptorsensorside effectsmall moleculespatiotemporaltooltwo photon microscopy
项目摘要
Summary
The most abundant endocannabinoid (eCB) in brain, 2-arachidonoyl glycerol (2-AG), is inactivated by two
enzymes: monoacylglycerol lipase (MAGL) and α/β hydrolase domain-contain 6 (ABHD6) that differ in their
hydrolyzing activities and subcellular localization (presynaptic and postsynaptic, respectively). Accordingly,
selective inhibition of each enzyme results in different spatiotemporal enhancement of 2-AG-CB1R signaling in
the brain, and potentially synergistic therapeutic benefits.
We recently gathered results showing that stimulated increase in 2-AG production is reliably measured using
GRABeCB2.0, a recently developed 2-AG sensor. Remarkably, metabotropic receptor mediated increase in 2-AG
is controlled by ABHD6, whereas ionotropic receptor-dependent increase in 2-AG is not controlled by ABHD6.
These results raise the question of how MAGL controls stimulation-dependent 2-AG production?
Demonstrating that receptor-dependent increases in 2-AG production and activity at CB1R signaling are
differentially controlled by ABHD6 and MAGL would provide an additional level of mechanistic distinction
between these eCB-hydrolyzing enzymes. To increase our understanding of the respective roles of ABHD6 and
MAGL in controlling 2-AG-CB1R signaling in brain, we initiated an effort and have now successfully validated the
GRABeCB2.0 pharmacological profile in neural cells in culture and identified several stimuli that increase 2-AG
production. Based on this premise, we propose to address the following two questions in mouse neurons in
primary culture and striatal slices using live-cell fluorescence microscopy, two-photon microscopy and
electrophysiology:
Aim 1: Which stimuli increase 2-AG production and GRABeCB2.0 signal in neurons?
Aim 2: How do ABHD6 and MAGL differentially control stimuli-dependent increases in 2-AG-CB1R
signaling in neurons?
Completion of the work outlined in this new R21 grant proposal will provide a comprehensive understanding of
the respective role of ABHD6 and MAGL in controlling 2-AG-CB1R signaling in the brain. Our long-term goal is
to increase our understanding of the molecular, cellular, and system’s level differences by which ABHD6 and
MAGL control eCB signaling in brain, a body of work that will help develop novel therapeutics with reduced
potential for abuse and adverse effects produced by classic cannabinoid agonists.
概括
大脑中最丰富的内源性大麻素(ECB),2-芳烃甘油(2-AG),被两个人灭活
酶:单酰基甘油脂肪酶(MAGL)和α/β水解酶结构域6(ABHD6),它们的不同
水解活性和亚细胞定位(分别为突触前和突触后)。
选择性抑制每种酶会导致2-AG-CB1R信号在不同的时空增强
大脑以及潜在的协同治疗益处。
我们最近收集的结果表明,使用刺激的2ag产生增加是可靠的
Grabecb2.0,最近开发的2AG传感器。值得注意的是,代谢受体介导的2-AG的增加
由ABHD6控制,而Ionotropic接收器依赖于2-AG的增加不受ABHD6的控制。
这些结果提出了一个问题,即MAGL如何控制依赖模拟的2AG产生?
证明接收器依赖性在2AG的产生和CB1R信号的活性中增加是
由ABHD6和MAGL差异控制将提供额外的机械区别
在这些欧洲央行 - 水解酶之间。为了增加我们对ABHD6各自角色的理解
MAGL在控制大脑中的2-AG-CB1R信号传导时,我们开始了一项努力,现在已经成功验证了
培养神经细胞中的Grabecb2.0药理学特征,并确定了增加2 AG的几种刺激
生产。基于此前提,我们建议在鼠标神经元中解决以下两个问题
使用活细胞荧光显微镜,两光子显微镜和
电生理学:
AIM 1:哪些刺激会增加神经元中的2AG产生和grabecb2.0信号?
AIM 2:ABHD6和MAGL如何差异控制刺激依赖性依赖于2-AG-CB1R
神经元的信号传导?
这项新的R21赠款提案中概述的工作的完成将提供全面的理解
ABHD6和MAGL在控制大脑中2-AG-CB1R信号传导中的相对作用。我们的长期目标是
为了增加我们对ABHD6和ABHD6和系统水平差异的理解
MAGL控制欧洲央行信号在大脑中,这是一种有助于发展新疗法的工作体系
经典大麻素激动剂产生的滥用和不良反应的潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nephi Stella其他文献
Nephi Stella的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nephi Stella', 18)}}的其他基金
Role of CB1R expressed in the prefrontal cortex in the control of locomotion
前额皮质表达的 CB1R 在运动控制中的作用
- 批准号:
10590320 - 财政年份:2023
- 资助金额:
$ 19.44万 - 项目类别:
Differential response of glioblastomas to microtubule targeting agents
胶质母细胞瘤对微管靶向剂的差异反应
- 批准号:
10650168 - 财政年份:2020
- 资助金额:
$ 19.44万 - 项目类别:
Differential response of glioblastomas to microtubule targeting agents
胶质母细胞瘤对微管靶向剂的差异反应
- 批准号:
10208829 - 财政年份:2020
- 资助金额:
$ 19.44万 - 项目类别:
Impact on adult mouse brain of oral THC and CBD consumption during adolescence
青春期口服 THC 和 CBD 对成年小鼠大脑的影响
- 批准号:
10206087 - 财政年份:2020
- 资助金额:
$ 19.44万 - 项目类别:
Molecular mechanism of ABHD6 enzymatic activity in neurons
神经元ABHD6酶活性的分子机制
- 批准号:
10040363 - 财政年份:2020
- 资助金额:
$ 19.44万 - 项目类别:
Differential response of glioblastomas to microtubule targeting agents
胶质母细胞瘤对微管靶向剂的差异反应
- 批准号:
10434745 - 财政年份:2020
- 资助金额:
$ 19.44万 - 项目类别:
Impact on adult mouse brain of oral THC and CBD consumption during adolescence
青春期口服 THC 和 CBD 对成年小鼠大脑的影响
- 批准号:
10039866 - 财政年份:2020
- 资助金额:
$ 19.44万 - 项目类别:
Novel microtubule-targeting agents for the treatment of glioblastoma multiform
用于治疗多形性胶质母细胞瘤的新型微管靶向药物
- 批准号:
9755531 - 财政年份:2018
- 资助金额:
$ 19.44万 - 项目类别:
Anti-Epileptic Action of ABHD6 Inhibitors as Treatment for Dravet Syndrome
ABHD6 抑制剂治疗 Dravet 综合征的抗癫痫作用
- 批准号:
9331065 - 财政年份:2017
- 资助金额:
$ 19.44万 - 项目类别:
相似海外基金
Effect of a potent and metabolically stable endocannabinoid receptor agonist on inflammasome-induced neuroinflammation in a comorbid mouse model of Alzheimer's disease and HIV
一种有效且代谢稳定的内源性大麻素受体激动剂对阿尔茨海默病和艾滋病毒共病小鼠模型中炎症小体诱导的神经炎症的影响
- 批准号:
10285175 - 财政年份:2020
- 资助金额:
$ 19.44万 - 项目类别:
Anti-Epileptic Action of ABHD6 Inhibitors as Treatment for Dravet Syndrome
ABHD6 抑制剂治疗 Dravet 综合征的抗癫痫作用
- 批准号:
9331065 - 财政年份:2017
- 资助金额:
$ 19.44万 - 项目类别: